MOTS-c & SS-31
Signaling versus structure. Which mitochondrial problem you actually have on a GLP-1 protocol, and which compound the pattern points to, before you change anything.
Not medical advice. Not a dosing recommendation. Not a sourcing guide. Every compound here is a research compound and every framework is an educational reference point drawn from published literature and documented research practice.
Are you a member?
This guide opens for members. If your membership includes the guides library, the Protocol Builder or Full Access, enter the email on your subscription and the full guide opens. If not, you can read it as a guest and see exactly what every section covers.
Not a member yet? Membership opens this guide, and depending on the tier it also opens the rest of the guides library, the Protocol Builder, the Stack Visualizer and the research search engine. See membership options
The Core Distinction
Signaling versus structure, and why the wrong first move misleads
Both compounds get pushed into the same bucket and then discussed as if the label solved the decision. People say mitochondrial support, energy support, or recovery support and treat the work as done. The label is broad enough to be technically true and still too weak to be useful. The first decision does not turn on whether both compounds touch the mitochondria, which are the parts of the cell that turn food into usable energy. It turns on what kind of problem is actually sitting underneath the complaint.
Most people arrive here because something that looked clean on paper turned blurry in real life. Energy stayed flat. Recovery lagged. Fat loss slowed while effort stayed high. The read then drifts. Was the body failing to switch into productive output, was the inner machinery running inefficiently, was it both, or was the whole picture contaminated by sleep debt, stimulant dependence, undereating, or chronic stress. Those are not minor details. They are the whole decision.
MOTS-c sits closer to signaling. It is a signaling peptide, meaning a molecule that carries an instruction rather than doing physical repair. It activates AMPK, the cell's energy sensor, and tells the body to make better use of the fuel it already has. The effect is demand-side. It raises the body's output signal, and research suggests it corrects the underutilization that shows up when that signal is low. Because it raises output, most people feel MOTS-c, and that felt effect is also why it gets misread.
SS-31 sits closer to structure. It targets the inner mitochondrial membrane, the physical layer where energy production either happens efficiently or leaks, and it protects cardiolipin, a fat molecule that keeps the energy-producing machinery in the right shape. The effect is supply-side. It does not add signal. It reduces the structural waste that was destroying the efficiency of the signal that already exists. Most people do not feel SS-31 acutely, and research suggests the correct output is the gradual disappearance of a problem, not the arrival of a new sensation.
Apply a signaling tool to a structurally taxed system and you may add strain without a clean payoff. Apply a repair tool to a system whose real issue is a blunted output signal and you may feel very little. In both cases the conclusion tends to sound the same, that the compound did not work. Based on the available data, the more honest conclusion is usually that the pattern was not identified before the experiment started.
Where each one shows up follows the protocol's phases, and this phase to pattern to compound mapping is this guide's diagnostic framework rather than settled clinical fact. Phase 1 is the early weeks where appetite suppression does the work and energy is usually fine, so mitochondrial compounds are premature. Phase 2 is the adaptation phase where fat loss slows and energy peaks after meals then crashes in the fasted window, which is where MOTS-c becomes a candidate. Phase 3 is the depletion phase where prolonged restriction, poor sleep, high stimulant load, and hard training without recovery have produced structural wear, energy is flat regardless of food timing, and recovery has stretched out, which is where SS-31 becomes a candidate.
The Foundation Gate
Four inputs that have to be stable before any compound gives you a clean read
Peptides amplify what is already there. They do not replace broken infrastructure. If any of the four below fails, that input is the first intervention, not a compound. Answer honestly. The gate is more useful when it fails.
Are you sleeping at least six hours most nights, and is the quality decent?
Short sleep raises cortisol, the stress hormone, and increases oxidative stress, which is the cellular wear that damages mitochondria. When they are under that load, every metabolic compound underperforms, and MOTS-c and SS-31 are no exception.
Fix sleep first. No compound has been shown to compensate for chronic short sleep, and running one on top of it wastes the compound and the read you would have got from it. Check whether GLP-1 injection timing or a recent dose change is contributing before assuming sleep is unrelated.
Can you get to normal energy without caffeine or other stimulants?
Daily stimulants raise cortisol and oxidative stress, so you are damaging mitochondria while trying to support them. Over time the body conserves energy harder, fatigue deepens, and the usual response is to escalate the stimulant. That cycle accelerates the problem it is treating.
Reduce the load before adding any metabolic compound. This one also shows up later as the stimulant trap, where the honest answer is that no compound is the right tool yet.
Has your stress load been manageable, or has it been high for months?
Cortisol sets the ceiling on what any compound can accomplish. It works directly against fat mobilization, it increases hunger, it degrades sleep, and it contributes to oxidative stress at the mitochondrial membrane, which is the exact structure SS-31 is meant to protect.
If chronic stress is unmanaged, that is the limiting variable. It does not need to be gone, only stable enough that it is not the thing holding everything down. Not the compound.
Are you training with resistance three to four times a week, consistently?
These compounds work by amplifying the body's response to physical demand. Without a consistent training signal there is nothing to amplify, so a metabolic compound added into a sedentary week produces a fraction of its documented effect.
Reestablish consistent training first, even at reduced volume. If training is absent, that is the limiting variable, not the compound.
The Diagnostic Path
Work the decision in order and reach the right tool in one move
The interactive decision path that walks the whole sequence in the order the guide runs it: audit the GLP-1 dose, check for the stimulant trap, clear the foundation gate, place NAD+ as the substrate, then read the pattern. Each step either clears the path or names the intervention, so you land on MOTS-c, SS-31, both, or neither, in one move instead of three months of rotating compounds.
The Three Compounds
NAD+ · MOTS-c · SS-31, side by side
The three compounds put directly next to each other, because the whole problem is that they get confused. What each one is, whether it is meant to be felt, which phase it belongs to, the research reference ranges, the storage that quietly ruins results, and the signs it is working against the signs something is off. This is the reference you come back to before every cycle.
The Three Patterns
Confirm which one you are actually looking at
The three patterns that cover most energy complaints, laid out so you can confirm which one you are actually in: Phase 2 metabolic flexibility failure, Phase 3 membrane damage, and the stimulant trap that masquerades as both. Each has a different tell, a different cause, and a different answer, and two of them look almost identical from the outside.
Pre-flight Checklists
Confirm the conditions before adding either compound
The specific conditions to confirm before adding MOTS-c and before adding SS-31. Not a bureaucratic list, the minimum diagnostic work that makes the experiment readable and the result usable. Both checklists save your progress so you can work through them across the days it takes to actually check each one.
Weekly Tracking
One entry per week, the columns that make the signal readable
A working tracking sheet for any compound run: one entry per week across a full cycle, with the specific columns that make the signal readable and guidance on which column matters for which compound. Six to eight weeks of consistent entries is what turns an assessment window into real data instead of a guess. It saves as you type, so the log is still here when you come back weeks later.
Worked Examples
The framework applied to four real situations
Four worked cases showing how the framework translates into a sequenced approach: a clean Phase 2, a Phase 3 with an oxidative history, a stimulant trap where no compound is appropriate yet, and a genuine overlap. Most people find their own situation in one of the four, which is faster than reading the theory and applying it cold.
Common Questions
The questions researchers actually ask at this decision point
The questions researchers actually ask at this decision point, answered directly: what a worsening signal means, why felt effect is the wrong thing to watch for SS-31, whether the two can run together, and how to tell Phase 2 from Phase 3. The answers are where the framework gets applied to the messy real cases the chapters do not cover cleanly.
Every guide, one membership
This is one of seven guides in the library. A guides library membership opens all of them. Full Access adds the Protocol Builder, the Stack Visualizer and the research search engine on top of that. One price either way.
Research Protocol Bible
The whole framework in one place. The phase model for deciding what to run and when, every compound sorted by what it actually does, the bottlenecks that stall a protocol, and a full reference section. If the other guides are chapters, this is the spine they hang off.
Unlock with membershipIntake & Output
The level above this one. Why a protocol stalls, and which side is actually failing, intake or output. The two failure modes that produce identical stalls, the self assessment that separates them, and the compound that fits each. Read it if you are not yet sure the problem is mitochondrial at all.
Unlock with membershipRetatrutide From First Dose to Full Protocol
Retatrutide start to finish. What the third receptor actually changes, what the early weeks tend to look like, how researchers read the thermogenic signal, and where it sits alongside the compounds people run with it. Built for the protocol being planned around reta.
Unlock with membershipRetatrutide, Tesamorelin, Ipamorelin
Three compounds read as one system. How a fat loss driver, a growth hormone signal and its amplifier get sequenced so they support each other instead of colliding, and the redundancy that quietly leaves one of the three doing nothing.
Unlock with membershipStack Compatibility Guide
The one that tells you whether two things in your protocol are fighting each other. Which compounds share a receptor or a mechanism, which pairings are redundant, and which are genuinely additive. The guide to open before you add anything to what you already run.
Unlock with membershipMOTS-c Guide
MOTS-c on its own, in depth. The mechanism in plain English, the energy pattern it addresses, the signs it is working, and the phase where it helps against the phase where it makes things worse.
Unlock with membershipThe rest of this guide, and everything above
The Foundation Gate above is the whole guide in miniature. Same depth, same refusal to sell you a compound you do not need. A guides library membership opens the remaining seven sections here and every guide in the library. Full Access adds the research tools on top of that.
See membership options